Phase I dose escalation study of Linsitinib (OSI-906) and Erlotinib in patients with advanced solid tumors за авторством Macaulay, V, Middleton, M, Eckhardt, S, Rudin, C, Juergens, R, Gedrich, R, Gogov, S, McCarthy, S, Poondru, S, Stephens, A, Gadgeel, S